VAERS Explorer
Back to explore

Report #2895722

Received May 7, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
NM
Recovered
Unknown
Vaccinated
Apr 24, 2026
Onset
Apr 24, 2026
Days to onset
0
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNKY003462

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

No additional AE; GARDASIL9 was administered to one patient after its expiry date; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 24-Apr-2026, the patient was vaccinated with an expired Human Papillomavirus 9-Valent Vaccine, Recombinant (GARDASIL 9) suspension for injection, 0.5 ml, lot# Y003462, expiration date: 23-Apr-2026 (dose number, route of administration and anatomical location were not reported), for prophylaxis (Expired product administered). Vaccine has not experienced temperature excursion. No symptoms and additional adverse events were reported.